Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,235,149
-$1,465,457 QoQ
Shares Held
312,696
-21.6% QoQ
Ownership
0.210%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2021
20 quarters on record
Voting authority
Sole 97.53754445211963.ToString("F0")%
Shared 0.ToString("F0")%
None 2.4624555478803694.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. MDXG ranks #132 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in MDXG
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,235,149 | 312,696 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,700,606 | 398,908 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $4,915,483 | 704,224 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,837,781 | 791,781 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,609,947 | 606,572 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $2,337,101 | 242,942 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $766,828 | 129,751 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $282,723 | 40,797 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,004,357 | 130,436 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $3,745,921 | 427,129 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $4,838,467 | 663,713 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,444,286 | 974,930 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $1,813,199 | 531,730 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,579,668 | 568,226 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,340,109 | 466,937 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,930,392 | 556,309 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,679,349 | 568,864 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,753,152 | 455,820 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $1,144,849 | 188,919 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $345,188 | 27,593 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||